Effects of Erand mul arka eye drop on simple allergic conjunctivitis.
Phase 2
- Conditions
- Health Condition 1: H103- Unspecified acute conjunctivitis
- Registration Number
- CTRI/2022/05/042345
- Lead Sponsor
- Vivek P Harne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Both male and female
2)Between the age group of 18 to 60 yrs will be included in the study.
3)Patient suffering from Toda (pricking pain), Sangharsh (foreign body sensation), Vishushk Bhav (dryness feeling), Shishirasruta (cline/watery discharge), Alpashopha (mild chemosis) will be selected irrespective of their sex, education, socio economic status & religion.
Exclusion Criteria
1)Patient not willing for trial
2)Pregnant & lactating women.
3)Patient who need surgical and other in intervention.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to see effect of Erand Mul Arka Eye drop and Olopetadine 0.1 % Eye drop in Vataj Abhi Shyand (simple allergic conjunctivitis)To review ancient literature on Vataj Abhi Shyand (simple allergic conjunctivitis) <br/ ><br>Timepoint: 7th and 15th days
- Secondary Outcome Measures
Name Time Method evidence base support for the effect of Erand Mul Eye Drop as mentioned in our ancient literature <br/ ><br> provide simple and effective treatment for Vataj Abhi Shyand (simple allergic conjunctivitis) <br/ ><br>Timepoint: throught study for 15 days